Skip to content
10-K

Annual Report

CAMP4 Therapeutics Corporation CAMP

0001736730-26-000016

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 4, 2026 51.92M sh
Shares Diluted FY 2025 · Dec 31, 2025 30.38M sh
Shares Diluted FY 2025 · Dec 31, 2024 4.69M sh
Capex FY 2025 · Dec 31, 2025 $279K
Capex FY 2025 · Dec 31, 2024 $441K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$29.55M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$45.56M
Cash And Equivalents FY 2025 · Dec 31, 2025 $109.52M
Cash And Equivalents FY 2025 · Dec 31, 2024 $64.04M
Stockholders Equity FY 2025 · Dec 31, 2025 $47.7M
Stockholders Equity FY 2025 · Dec 31, 2024 $63.14M
Stockholders Equity FY 2025 · Dec 31, 2023 −$123.73M
Current Liabilities FY 2025 · Dec 31, 2025 $15.51M
Current Liabilities FY 2025 · Dec 31, 2024 $9.6M
Total Liabilities FY 2025 · Dec 31, 2025 $70.1M
Total Liabilities FY 2025 · Dec 31, 2024 $15.16M
Current Assets FY 2025 · Dec 31, 2025 $114.1M
Current Assets FY 2025 · Dec 31, 2024 $66.38M
Total Assets FY 2025 · Dec 31, 2025 $117.81M
Total Assets FY 2025 · Dec 31, 2024 $78.31M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.65
Eps Diluted FY 2025 · Dec 31, 2024 −$11.04
Eps Basic FY 2025 · Dec 31, 2025 −$2.65
Eps Basic FY 2025 · Dec 31, 2024 −$11.04
Sga Expense FY 2025 · Dec 31, 2025 $17.36M
Sga Expense FY 2025 · Dec 31, 2024 $14.92M
Rd Expense FY 2025 · Dec 31, 2025 $38.2M
Rd Expense FY 2025 · Dec 31, 2024 $38.82M
Net Income FY 2025 · Dec 31, 2025 −$80.4M
Net Income FY 2025 · Dec 31, 2024 −$51.79M
Operating Income FY 2025 · Dec 31, 2025 −$52.56M
Operating Income FY 2025 · Dec 31, 2024 −$53.09M